Real-world performance of an eye-tracking-based diagnostic aid for autism spectrum disorder.
Product Description:
To evaluate the real-world performance, clinical feasibility, and predictive validity of an FDA-cleared, eye-tracking-based diagnostic device for autism spectrum disorder (ASD). Retrospective data were gathered from five clinical sites between August 2023 and November 2025. Primary outcomes included device success rates and expert clinician diagnoses.
Keyword(s):
autism/ADC, Medical technology and advancement, Developmental/behavioral health
Product/Publication Type(s):
Peer-reviewed publications in scholarly journals submitted
Target Audience:
Professionals, Policymakers
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A